HUP0004671A3 - 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof - Google Patents

5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof

Info

Publication number
HUP0004671A3
HUP0004671A3 HU0004671A HUP0004671A HUP0004671A3 HU P0004671 A3 HUP0004671 A3 HU P0004671A3 HU 0004671 A HU0004671 A HU 0004671A HU P0004671 A HUP0004671 A HU P0004671A HU P0004671 A3 HUP0004671 A3 HU P0004671A3
Authority
HU
Hungary
Prior art keywords
naphthyridin
oxadiazolyl
derivatives
substituted
pharmaceutical compositions
Prior art date
Application number
HU0004671A
Other languages
English (en)
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Publication of HUP0004671A2 publication Critical patent/HUP0004671A2/hu
Publication of HUP0004671A3 publication Critical patent/HUP0004671A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HU0004671A 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof HUP0004671A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20717997 1997-07-15
PCT/JP1998/003134 WO1999003857A1 (fr) 1997-07-15 1998-07-14 Derives de 5-substitue-3-oxadiazolyl-1,6-naphtyridin-2(1h)-one

Publications (2)

Publication Number Publication Date
HUP0004671A2 HUP0004671A2 (hu) 2001-05-28
HUP0004671A3 true HUP0004671A3 (en) 2001-12-28

Family

ID=16535559

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004671A HUP0004671A3 (en) 1997-07-15 1998-07-14 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof

Country Status (29)

Country Link
US (2) US6172079B1 (hu)
EP (1) EP1010699B1 (hu)
JP (1) JP3390453B2 (hu)
KR (1) KR100508392B1 (hu)
CN (1) CN1134437C (hu)
AR (1) AR013222A1 (hu)
AT (1) ATE297923T1 (hu)
AU (1) AU735960B2 (hu)
BR (1) BR9811474B1 (hu)
CA (1) CA2296427C (hu)
DE (1) DE69830595T2 (hu)
DK (1) DK1010699T3 (hu)
EE (1) EE04372B1 (hu)
ES (1) ES2244065T3 (hu)
HK (1) HK1028895A1 (hu)
HU (1) HUP0004671A3 (hu)
ID (1) ID24047A (hu)
IL (2) IL133512A0 (hu)
NO (1) NO314999B1 (hu)
NZ (1) NZ501814A (hu)
PL (1) PL191200B1 (hu)
PT (1) PT1010699E (hu)
RU (1) RU2188199C2 (hu)
SI (1) SI1010699T1 (hu)
SK (1) SK285913B6 (hu)
TR (1) TR200000103T2 (hu)
TW (1) TW486479B (hu)
WO (1) WO1999003857A1 (hu)
ZA (1) ZA985870B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI298068B (en) * 2000-06-21 2008-06-21 Dainippon Sumitomo Pharma Co Pharmaceutical composition for schizophrenia
TW200533371A (en) * 2004-04-15 2005-10-16 Dainippon Pharmaceutical Co Medicament comprising a combination of an acetylcholinesterase inhibitor and a 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
EP2095812A4 (en) 2006-10-25 2011-07-13 Dainippon Sumitomo Pharma Co NON-AGGLUTINANT GRANULAR PREPARATION
BRPI0908849A2 (pt) * 2008-02-22 2015-08-25 Irm Llc Composto e composições como c-kit e inibidores de pdgfr quinase
WO2010002451A1 (en) * 2008-07-01 2010-01-07 Concert Pharmaceuticals, Inc. Naphthyridin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415580A (en) * 1982-08-02 1983-11-15 Sterling Drug Inc. Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same
US4650806A (en) * 1985-01-14 1987-03-17 Sterling Drug Inc. Cardiotonic 5-(heterylcarbonyl)-pyridones
US4567186A (en) * 1985-01-14 1986-01-28 Sterling Drug Inc. 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
IL101860A0 (en) * 1991-05-31 1992-12-30 Ici Plc Heterocyclic derivatives
AU664912B2 (en) * 1992-09-02 1995-12-07 Dainippon Pharmaceutical Co. Ltd. Novel 3-oxadiazolyl-1,6-naphthyridine derivatives
JP2002241379A (ja) * 1997-03-21 2002-08-28 Dainippon Pharmaceut Co Ltd 3−オキサジアゾリルキノキサリン誘導体

Also Published As

Publication number Publication date
SK285913B6 (sk) 2007-11-02
WO1999003857A1 (fr) 1999-01-28
ES2244065T3 (es) 2005-12-01
AR013222A1 (es) 2000-12-13
KR20010021824A (ko) 2001-03-15
TR200000103T2 (tr) 2000-06-21
CN1134437C (zh) 2004-01-14
CA2296427C (en) 2006-11-14
HUP0004671A2 (hu) 2001-05-28
US6172079B1 (en) 2001-01-09
NO20000183D0 (no) 2000-01-14
DE69830595D1 (de) 2005-07-21
PL191200B1 (pl) 2006-03-31
CA2296427A1 (en) 1999-01-28
DK1010699T3 (da) 2005-10-10
PL338085A1 (en) 2000-09-25
EE200000029A (et) 2000-10-16
PT1010699E (pt) 2005-08-31
NZ501814A (en) 2002-02-01
AU8129498A (en) 1999-02-10
ATE297923T1 (de) 2005-07-15
CN1264380A (zh) 2000-08-23
EP1010699B1 (en) 2005-06-15
ZA985870B (en) 1999-01-27
IL133512A (en) 2007-06-17
RU2188199C2 (ru) 2002-08-27
SI1010699T1 (en) 2005-10-31
SK532000A3 (en) 2000-09-12
AU735960B2 (en) 2001-07-19
HK1028895A1 (en) 2001-03-09
DE69830595T2 (de) 2006-05-11
TW486479B (en) 2002-05-11
ID24047A (id) 2000-07-06
NO20000183L (no) 2000-03-07
KR100508392B1 (ko) 2005-08-17
NO314999B1 (no) 2003-06-23
BR9811474B1 (pt) 2009-05-05
EP1010699A4 (en) 2001-09-12
EE04372B1 (et) 2004-10-15
US6277993B1 (en) 2001-08-21
JP3390453B2 (ja) 2003-03-24
EP1010699A1 (en) 2000-06-21
BR9811474A (pt) 2000-08-15
IL133512A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
IL127056A (en) Aryl pyrimidine derivatives, their preparation and pharmaceutical compositions comprising them
HUP0100179A3 (en) Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0100941A3 (en) Quinoline, quinazoline and pyrido-pyrimidine derivatives and pharmaceutical compositions thereof
HUP0001243A3 (en) Nicotinamide derivatives and pharmaceutical compositions containing them
HUP0100397A3 (en) Tetrahydro- or octahydrobenzonaphtyridin and quinolin derivatives, pharmaceutical compositions thereof and process for their preparation
IL123036A (en) 1-phenyl-8-substituted-1,3,8-triaza-spiro¬4.5¾decan-4-one derivatives their preparation and pharmaceutical compositions containing them
HUP0002869A3 (en) Benzothiophenecarboxamide derivatives, pharmaceutical compositions thereof and intermediates
HUP0105133A3 (en) Quinoline derivatives and quinazoline derivatives, pharmaceutical compositions containing them and their use
HUP0102313A3 (en) Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates
IL150346A0 (en) Benzazole derivatives, their preparation and pharmaceutical compositions containing them
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0000851A3 (en) Novel pyrimidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0105003A3 (en) 2-oxy-4h-3,1-benzoxazin-4-one derivatives, their use and pharmaceutical compositions containing them
HUP0103921A3 (en) [1,2,4]triazolo[1,5-c]pyrimidine derivatives and pharmaceutical compositions thereof
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
NZ322197A (en) Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof
HUP0102117A2 (hu) Imidazo[1,2-a]piridin-származékok és ezeket tartalmazó gyógyászati készítmények
HUP0201649A3 (en) Purine derivatives, preparation method and pharmaceutical compositions containing same
HUP0204154A3 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP9900563A3 (en) Chinoline-2-(1h)-ones, their production, pharmaceutical compositions and use
IL107431A0 (en) Substituted penems and derivatives therof, their preparation and pharmaceutical compositions comprising them
HUP0203539A3 (en) Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them
HUP0004671A3 (en) 5-substituted-3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivatives and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., JP

Free format text: FORMER OWNER(S): DAINIPPON PHARMACEUTICAL CO., LTD., JP

FD9A Lapse of provisional protection due to non-payment of fees